Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the efficacy and safety/tolerability of 12 weeks administration of PH-797804 in adults with moderate to severe COPD (GOLD stage II/III) on a background of salmeterol xinafoate/fluticasone propionate combination.
Critère d'inclusion
- Chronic Obstructive Pulmonary Disease (COPD)